相关实验视频
Updated: Jul 4, 2025

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
糖尿病视网膜病变 - - 从病理生理学到治疗:一篇综述
Randhir Singh1,2, Aditya Walia3, Jasleen Kaur3
1Department of Pharmacology, Central University of Punjab, Bathinda, Punjab, India.
糖尿病视网膜病变 (DR) 是糖尿病患者失明的主要原因. 了解它的分子病原体对于开发有效的治疗方法来预防视力丧失至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病视网膜病变 (DR) 是最常见的糖尿病并发症,导致不可逆转的视力丧失.
- 病原发生涉及微血管变化,炎症,氧化应激和视网膜神经退行.
- 目前的治疗方法有限,这凸显了对新型治疗策略的需求.
研究的目的:
- 审查糖尿病视网膜病变的分子病变发生.
- 讨论目前和潜在的未来DR的治疗方法.
- 强调分子机制与治疗开发之间的联系.
主要方法:
- 对糖尿病视网膜病变研究的文献综述.
- 对涉及DR的分子通路的分析.
- 综合关于治疗策略的信息.
主要成果:
- DR涉及复杂的分子通路,包括炎症和氧化应激.
- 视网膜神经退行是DR进展的关键特征.
- 针对特定的分子机制为新的治疗提供了潜力.
结论:
- 对DR分子病原学的全面理解是必不可少的.
- 开发基于分子机制的向疗法可以改善患者的治疗结果.
- 对DR分子通路的进一步研究对于有效管理至关重要.
更多相关视频
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
相关概念视频
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Photoreceptors and Visual Pathways
Glaucoma: Overview
Diabetes: Symptoms, Diagnosis, and Complications